|
Home | Medical-Newswire.Com:
|
(EMAILWIRE.COM, April 10, 2012 ) New York, NY -- With a new trading quarter upon us, the broad markets as a whole look ready to take a downswing after a strong first quarter and months of running higher as the global economy demonstrated a strength and resiliency not seen for years. Although a downswing - or "correction", as some might term it - could be in the works, there are some companies and stocks out there with enough pending news, catalysts and developments that may allow them to weather the storm and outperform the near-term market trends.
Immunocellular Therapeutics (IMUC) is one that has already well-outperformed the market this year and could maintain strength into any general downswing.
Over the course of the past six months Immunocellular has emerged from one of a quite few speculative Phase II cancer immunotherapy companies to become a potential front-runner in the next generation of such treatments.
Fueled by encouraging survival data from early trials and positive developments on the business front, IMUC has soared past the two dollar mark with ease and even breached the three dollar barrier for a period, a level that the share price still flirts with on a near-daily basis, even as the market as a whole is on a breather.
Other developments and pending catalysts also bode well for both the short and long term future of Immunocellular.
For full report visit: http://vfcsstockhouse.com/blog/article/-immunocellular-therapeutics-may-be-immune-to-a-broad-market-downturn
For this week's list of stocks to watch visit: http://vfcsstockhouse.com/blog/article/-weekly-stock-watch-april-9-13-ampe-pbth-imuc-nby-nriff-cndo-siga-imsc-yhoo-fb-siri-cvm-aapl-sbux-mcd-agen
For Tuesday's stock market roundup visit: http://vfcsstockhouse.com/blog/article/-tuesday-morning-roundup-facebook-yhoo-aol-msft-imsc-ctso-cpst-sppi-amrn-cldx-ampe
About VFCsStockHouse.com:
VFC's Stock House is an information and research outlet that brings new ideas to the table and opens discussions for a broad spectrum of investors, with a strong focus on - but not limited to - biotech stocks and the pharmaceutical and healthcare sectors. VFC's Stock House provides individual company profiles, write-ups and reports as well as giving general insights into broader-market news through various 'Stock Watch' lists. At the conclusion of most weeks, VFC's Stock House issues a "Weekly Stock Watch" that examines news items, stocks and stories that made headlines during the previous trading week, but may also make headlines or influence trends during the upcoming week as well. The information contained within the pages of VFC’s Stock House are not intended to be taken as advice, but as a starting point where investors can follow up with their own DD and devise their own entry and exit strategies.
Follow VFC's Stock House on Twitter: https://twitter.com/#!/VFCsStockHouse
'Like' VFC's Stock House on Facebook: http://www.facebook.com/pages/VFCs-Stock-House/143724412345213
For full disclaimer visit: http://vfcsstockhouse.com
VFC's Stock House
VFC
240-786-2111
vfc@vfcsstockhouse.com 
Source: EmailWire.com
|
|
|
|
